Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT2015090621315N2
IRCT2015090621315N2
Completed
Phase 3

A randomized, double blind clinical trial to evaluate biosafety of trastuzumab produced by aryogen company (™Hercease) in comparison to Roche company trastuzumab (™Herceptin)

Aryogene pharmed company0 sites20 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBenign neoplasm of breast.Benign neoplasm of connective tissues and soft parts of breast

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Benign neoplasm of breast.
Sponsor
Aryogene pharmed company
Enrollment
20
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Aryogene pharmed company

Eligibility Criteria

Inclusion Criteria

  • •inclusion criteria: female aged 18\- 70 years at the time of signing the informed consent form; HER2\+ breast cancer in ich experiment with 3\+ and or 2\+ that has reported positive by FISH method; ECOG grade between 0\-1; LVEF 55% or more.
  • •exclusion criteria: bilateral metastatic breast cancer; other malignancies; renal, liver, bone marrow and cardiac insufficiencies; hypertention; pregnancy or planning to be pregnant.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
A double-blind, randomized clinical trial to evaluate the efficacy of Duloxetine against pain associated with Parkinson's disease with depression.PD patients
JPRN-UMIN000016893Ehime University Hospital Dept. of Clinical pharmacology and Neurology50
Completed
Not Applicable
Evaluation of the relationship between salt intake and blood pressure in different amounts of salt consumed
RBR-7yjwpfniversidade Federal de Goiás
Recruiting
Phase 2
The effect of Memantine on cognition disorders induced by Electroconvulsive therapy (ECT)Post ECT cognition disordersMental Health - Other mental health disorders
ACTRN12614000619640Mohammad Abbasinazari40
Active, not recruiting
Phase 2
Effect of allopurinol on prevention of pancreatitis after Endoscopic Retrograde Cholangio Pancreatography(ERCP)
ACTRN12611000182998Mohammad Abbasinazari500
Not yet recruiting
Not Applicable
A study to compare the duration of pain relief with clonidine and morphine added to local anaesthetic drug Bupivacaine in spinal anaesthesia for patients undergoing vaginal hysterectomy.Health Condition 1: O- Medical and Surgical
CTRI/2024/07/070200Rajesh Ravi